Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Two siblings with limb-girdle muscular dystrophy type 2E responsive to deflazacort.

Neuromuscular disorders : NMD - 1 Feb 2010

Wong-Kisiel Lily C, Kuntz Nancy L

Abstract excerpt

Two siblings were evaluated for progressive proximal weakness and elevated creatine kinase. Immunohistochemical staining in the brother's muscle biopsy showed near absence of all four sarcoglycan subunits. Clinical progression prompted a trial of deflazacort in both siblings. At 22 months of drug...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biopsy
Share to Immunosuppressive Agents
Share to Muscle, Skeletal

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Muscle Strength

Share to Muscular Dystrophies, Limb-Girdle

Share to Sarcoglycans

Share to Severity of Illness Index

Share to Siblings

Source

Identifiers

PMID: 20071171
DOI: 10.1016/j.nmd.2009.11.005

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20071171-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Two siblings with limb-girdle muscular dystrophy type 2E responsive to deflazacort.PMID 20071171Read ↗

Meta-analyses of deflazacort versus prednisone/prednisolone in patients with nonsense mutation Duchenne muscular dystrophySemantic proximity Read ↗

A novel mutation in two families with limb-girdle muscular dystrophy type 2C.Semantic proximity Read ↗

Limb‐girdle muscular dystrophy type 2D gene therapy restores α‐sarcoglycan and associated proteinsSemantic proximity Read ↗

A novel compound heterozygous dysferlin mutation in Miyoshi myopathy siblings responding to dantrolene.Semantic proximity Read ↗

An Overview of Recent Therapeutics Advances for Duchenne Muscular Dystrophy.Semantic proximity Read ↗

Unmet Needs and Evolving Treatment for Limb Girdle Muscular DystrophiesSemantic proximity Read ↗

Neurology Care, Diagnostics, and Emerging Therapies of the Patient With Duchenne Muscular DystrophySemantic proximity Read ↗

Towards a Cure: Emerging Therapeutic Advances for DMD, LGMD, and GNEM- Insights from Pre-Clinical and Clinical ResearchSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.